Below is a daily summary of links to the latest SPAC news and rumors gathered across the web.
Latest SPAC News: Hedge fund bets against SPAC tied to Trump, Indian government eyes SPAC framework to enable new listing route, and Rezolve partners with Computop
Hedge Fund Bets Against a SPAC Tied to Trump After Truth Social ‘Disaster’
Hedge fund Kerrisdale Capital Management is betting against the shell company tied to Donald Trump, wagering that it will fail to get regulatory approval to merge with his media company and take it public.
Shares of Digital World Acquisition Corp. (NASDAQ:DWAC) have more room to fall, according to a report Wednesday from Kerrisdale announcing its short position. DWAC gave misleading statements in registration documents and the high-profile nature of its potential combination with the former president’s company, Trump Media & Technology Group, is an “ideal way” for regulators to send a message to the broader industry, it said.
READIndian Government Eyes SPAC Framework to Enable New Listing Route
The Indian government is looking at putting in place a regulatory framework for SPACs in the statutes to aid the possible listing of Indian companies in the country. The Company Law Committee, which submitted its report on a fresh set of amendments to the Companies Act, has suggested introduction of enabling provisions in the law to list a SPAC on domestic or international exchanges.
The panel has gone on to suggest that the provisions allowing Indian companies to list directly on overseas exchanges should be operationalized. While Parliament allowed the move, the revenue department has refused to address issues related to taxation.
READRezolve and Computop Announce Strategic Partnership on Mobile Engagement and Payments, Extending Rezolve’s Presence in German Markets and Beyond
Rezolve, a leader in mobile commerce and engagement, and Computop, a leading payment service provider, today announced a strategic partnership agreement to combine their respective strengths in mobile engagement and payment processing to improve service for users of both globally.
On December 17, 2021, Rezolve announced that it had entered into a definitive business combination agreement with Armada Acquisition Corp. I (NASDAQ: AACI).
READCohen & Co. Capital Markets Hires Ex-Deutsche SPAC Banker Sun
Cohen & Co. Capital Markets, an arm of JVB Financial Group LLC, hired Brandon Sun, a former Deutsche Bank AG banker specializing in special purpose acquisition companies, according to Bloomberg.
Sun, who is based in New York, is slated to start in coming weeks as a managing director reporting to Jerry Serowik, the firm’s head of capital markets and a Wells Fargo & Co. (NYSE:WFC) alum.
READ
AGBA (NASDAQ:AGBA) stock is up over +90% this morning following a +211% premarket spike on news it has signed a definitive agreement to combine with social streaming video platform Triller. AGBA, the company itself, was formed by the $555 million combination between a SPAC of the same name and TAG Companies, a financial services firm...
At the SPAC of Dawn Since closing its combination with DHC last month, AI customer engagement firm BEN (NASDAQ:BNAI) has rolled out new partnerships with call center and healthcare clients. And, while it faces a fair bit of competition in the chatbot realm, several high-profile institutions have demonstrated that creating one that provides useful services...
Blue Ocean (NASDAQ:BOCN) provided significantly more texture today in the presentation for its $275 million combination with Asian digital media group TNL Mediagene, which it expects to hit profitability in the second half of the year despite a slight shakeup in financing for the transaction. The first big update in the first investor deck is...
At the SPAC of Dawn A brand new market may have just opened up for space de-SPACs as NASA administrator Bill Nelson announced a shift in the agency’s $11 billion program for a mission to return samples from Mars. Rather than rely on the agency’s internal technologies that would be predicted to get a sample...
Overall deal flow between SPACs and biotech firms has slowed over the last year, but some pending FDA changes could breathe new life into particular business models within the space. In particular, the FDA has asked Congress as part of its 2025 Legislative Proposals to eliminate the interchangeability designation for biosimilar medications, claiming the existing...